Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes

  • Guntram Schernthaner (Corresponding Author)
  • , Naim Shehadeh
  • , Alexander S. Ametov
  • , Anna V. Bazarova
  • , Fahim Ebrahimi
  • , Peter Fasching
  • , Andrej Janež
  • , Péter Kempler
  • , Ilze Konrāde
  • , Nebojša M. Lalić
  • , Boris Mankovsky
  • , Emil Martinka
  • , Dario Rahelić
  • , Cristian Serafinceanu
  • , Jan Škrha
  • , Tsvetalina Tankova
  • , Žydrūnė Visockienė

Research output: Contribution to journal › Article › peer-review

129 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes'. Together they form a unique fingerprint.

Medicine and Dentistry